ID™ SARS-CoV-2 / Influenza Triplex RT-PCR

Triplex RT-PCR test allowing for the detection and differentiation of SARS-CoV-2 and Influenza A/B viruses in humans.

Qualitative triplex RT-PCR which simultaneously amplifies SARS-CoV-2, Influenza A and Influenza B target sequences and an endogenous internal control.

This test was developed by Innovative Diagnostics’ sister company: ID-Solutions, which is specialized in circulating DNA diagnostics in human oncology. The test is CE-IVD marked.

  • High sensitivity: LOD(95%) is < 12 copies/PCR
  • Positive Extraction Control (PEC): unique on the market, for the validation of the extraction process and reverse transcriptase step
  • Endogenous internal control to ensure sample presence and the absence of false negatives
  • Ready-to-use
  • Results are obtained within 1 hour
  • Validated on the main thermocyclers on the market
Our diagnostic tests are to be performed in laboratories by skilled technicians. They are distributed to laboratories only and are not available to private individuals.
If you are a private individual seeking a COVID-19 test, please consult healthcare professionals.

Specifications

Method RT-PCR - Triplex - Qualitative
Species Humans
Sample types Nasopharyngeal, oropharyngeal swabs or sputum samples

Ordering information

Product code Reactions
IDRESPI-P1-100 100
IDRESPI-P1-500 500

Associated products